Also, restoration of HEVM ectodomain by soluble HVEM protein or HVEM-producing and CD19-targeted CAR-T cells were tumor-suppressive in MYC + /BCL2 + DLBCL cell lines and BCL2 overexpressing lymphoma xenograft model, respectively [134]. This evidence concerns the gene BCL2 and neoplasm.